@juliez49 @SheffWHO2018 @FoxNewsSHEFFWHO @BaijuSheffWHO Funding can come from multiple sources such as national international development. The presence of pharma is needed to supply products but companies need to do more to support the fight against counterfeit products and the use of generics as a supply option.
@FoxNewsSHEFFWHO @BaijuSheffWHO @SheffWHO2018 We nurture new research and the use of generics to reduce the cost burden to countries that need these medicines.
@FoxNewsSHEFFWHO @BaijuSheffWHO @SheffWHO2018 Yes but stockpiling resources and withholding vital medicines are not in the best interest of global health.
@FoxNewsSHEFFWHO @BaijuSheffWHO @SheffWHO2018 We should be aware of those that value profit over the lives and health of vulnerable individuals and regions.
France believes that surveillance is an incredibly important part of disease control. We hope that this merged resolution passes. #SheffWHO2018#sheffWHO
France is keen to support preparedness and surveillance efforts We agree with EURO 2.1 and would be interested in offering our expertise around these issues. @Sweden_ShefWHO @SheffWHO2018 #SheffWHO2018
France is keen to develop and support resolutions that would benefit France and its territories. We also want to strengthen health systems and dissuade from dependencies of vulnerable nations on pharma companies. #SheffWHO2018
As we head towards plenary today France is keen to support the papers that we are a signatory for as well as any other papers where we can offer our expertise. #SheffWHO#SheffWHO2018